Eric Thouvenot

Has grant

Professor of Neurology

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eric Thouvenot is a Professor of Neurology at Hôpital Universitaire Carémeau in France. His research areas include multiple sclerosis, cerebrovascular diseases, and the diagnostic accuracy of imaging techniques. Recent articles by Professor Thouvenot highlight correlations between choroid plexus enlargement and periventricular pathology, the efficacy of rituximab in treating NMOSD-AQP4 patients, and the impact of COVID-19 on individuals with multiple sclerosis.

Recent Grants

Grant: Close

D-lay MS

Open Date: 2013-01-01

Close Date: 2023-05-01

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

View details

Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eric Thouvenot

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

CD138 as a Specific CSF Biomarker of Multiple Sclerosis

Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults

Diagnostic Accuracy of Posterior/Anterior Periventricular WMH Ratio to Differentiate CAA From Hypertensive Arteriopathy

Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndrome

Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis

Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations

COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022

Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study

Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis

Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study

Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis

Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy on 1.5T T2*-Weighted Imaging

Spinal cord lesion mimicking a dysimmune myelitis revealing CANVAS syndrome

Association between brain metabolism and clinical course of motor functional neurological disorders.

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.

Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications

Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome.

Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.

Stress response in dissociation and conversion disorders: A systematic review.

Collaborators (11)

Christine Lebrun Frenay

David Laplaud

Anne L Astier

Sarah Coudray

Cristina Ramo-Tello

Ioana Maria Ion

Alexandra Garcia

Nicolas SALVETAT

Guy Laureys

Thibault MURA

Darin Okuda

Make your next move.